Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 97 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $106,455 | -25.6% | 19,533 | -7.3% | 0.00% | – |
Q2 2023 | $143,045 | -62.6% | 21,067 | -72.4% | 0.00% | – |
Q1 2023 | $382,078 | +109.9% | 76,263 | +505.6% | 0.00% | – |
Q3 2022 | $182,000 | -53.0% | 12,594 | -50.7% | 0.00% | – |
Q2 2022 | $387,000 | -75.7% | 25,569 | -80.9% | 0.00% | -100.0% |
Q1 2022 | $1,594,000 | +52.5% | 134,177 | +108.2% | 0.00% | – |
Q4 2021 | $1,045,000 | +43.3% | 64,449 | +152.2% | 0.00% | – |
Q3 2021 | $729,000 | +1520.0% | 25,559 | +1790.5% | 0.00% | – |
Q2 2021 | $45,000 | +1400.0% | 1,352 | +1187.6% | 0.00% | – |
Q1 2021 | $3,000 | 0.0% | 105 | +90.9% | 0.00% | – |
Q4 2020 | $3,000 | +200.0% | 55 | +243.8% | 0.00% | – |
Q3 2020 | $1,000 | -88.9% | 16 | -92.7% | 0.00% | – |
Q2 2020 | $9,000 | -93.3% | 219 | -95.7% | 0.00% | – |
Q1 2020 | $134,000 | +2133.3% | 5,141 | +2470.5% | 0.00% | – |
Q4 2019 | $6,000 | -98.5% | 200 | -98.7% | 0.00% | – |
Q3 2019 | $411,000 | +661.1% | 15,783 | +568.8% | 0.00% | – |
Q2 2019 | $54,000 | +38.5% | 2,360 | +60.2% | 0.00% | – |
Q1 2019 | $39,000 | -48.0% | 1,473 | -59.9% | 0.00% | – |
Q4 2018 | $75,000 | – | 3,674 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |